Use of DNA fingerprinting in decision making for considering closure of neonatal intensive care units because of Pseudomonas aeruginosa bloodstream infections.
D016470:Bacteremia / Q000175:diagnosis* / Q000401:mortality / Q000517:prevention & control; D017848:Blood-Borne Pathogens / Q000302:isolation & purification; D003428:Cross Infection / Q000175:diagnosis* / Q000517:prevention & control; D016172:DNA Fingerprinting; D003657:Decision Making; D005260:Female; D006271:Health Facility Closure; D006801:Humans; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D017053:Infection Control / Q000379:methods*; D007363:Intensive Care Units, Neonatal; D008297:Male; D016133:Polymerase Chain Reaction; D011552:Pseudomonas Infections / Q000175:diagnosis* / Q000401:mortality / Q000517:prevention & control; D011550:Pseudomonas aeruginosa / Q000235:genetics / Q000302:isolation & purification*; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D015996:Survival Rate; D014481:United States